The main market opportunities involve providing training and solutions for regulatory compliance and V&V best practices in regulated industries. This includes developing Master Validation Plans, ...
The life science industry faces opportunities in enhancing cGMP compliance by developing robust, risk-based Validation and Verification strategies. Training on creating effective Master Validation ...
Expert insights on QMSR compliance: transition steps, gap assessments, risk-based approach, and global harmonization with ISO ...
The US Food and Drug Administration (FDA) recently issued three warning letters to facilities in China, the US, and India for ...
Dublin, April 15, 2026 (GLOBE NEWSWIRE)-- The "Medical Device Software: Complying with the EU MDR, EU IVDR & FDA Regulations (June 22nd - June 26th, 2026)" training has been added to ...
Boston Cell Standards, Inc. (BCS), a private company bringing modern Quality tools and practices to Clinical Immunohistochemistry (IHC) testing worldwide, announced today that its IHC Reference ...
End-to-end digital twins for continuous automated manufacturing could slash production costs compared to batch manufacturing.
Over the past year, we have carefully considered whether — and how — life sciences companies can use AI tools in their clinical development ...
Medical Device Network on MSN
Merck KGaA and Remepy join forces to develop combo drug-digital therapies
The pair will develop drug-digital therapeutic combinations as a singular product, thus sidestepping reimbursement hurdles linked to individually approved digital therapies.
The National Medical Products Administration (NMPA) has published rules strengthening the supervision and administration of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results